NASDAQ: HHS
Harte Hanks Inc Stock

$2.53+0.07 (+2.85%)
Updated Jun 12, 2026
HHS Price
$2.53
Fair Value Price
$3.30
Market Cap
$18.74M
52 Week Low
$2.22
52 Week High
$5.39
P/E
-18.04x
P/B
0.93x
P/S
0.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$155.27M
Earnings
-$1.05M
Gross Margin
69.6%
Operating Margin
-0.73%
Profit Margin
-0.7%
Debt to Equity
3.5
Operating Cash Flow
-$1M
Beta
0.64
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HHS Overview

Harte Hanks, Inc. is an established global firm specializing in customer experience solutions, operating both domestically and internationally. Its business is structured around three primary divisions: Marketing Services, Customer Care, and Fulfillment & Logistics Services. Within Marketing Services, the company offers strategic guidance to clients, aiding in the design and execution of integrated omni-channel marketing initiatives. This comprehensive offering includes audience identification, detailed profiling, segmentation, prioritization, predictive analytics, and sophisticated data strategy development. Harte Hanks also ensures data quality through hygiene and cleansing services. The company implements campaigns across a wide array of channels, encompassing traditional media like print, broadcast, and direct mail, alongside digital platforms such as websites, mobile applications, display advertising, social media, search engine marketing, and voice interactions. Additionally, it provides digital infrastructure development, including website and app creation, e-commerce enablement, robust database construction and management, platform architecture design, marketing automation, and outsourced marketing operations solutions. The Customer Care segment focuses on managing client-consumer interactions, resolving issues ranging from hardware and software concerns to healthcare benefit plans, product recalls, and general service inquiries. This division leverages CRM and digital transformation strategies to facilitate meaningful customer engagement, ensuring seamless content integration between agent-assisted or AI-driven interfaces and self-service web tools or community forums. It also delivers intelligence-based B2B solutions, providing deep insights into audience behaviors and inspiring actions that drive measurable results. Finally, Fulfillment & Logistics Services covers product, print-on-demand, and mail fulfillment operations. This includes bespoke printing services, efficient management of product recalls, and the distribution of literature and promotional materials. The company further develops customized solutions tailored to engage specific audiences, target key customers, support conferences, and recognize employees, complemented by comprehensive third-party logistics (3PL) and freight optimization services. Harte Hanks, Inc. primarily serves diverse vertical markets, including business-to-business (B2B), consumer brands, financial services, retail, and healthcare sectors. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HHS's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Conglomerate

Industry Rating
D
HHS
Ranked
Unranked of 17

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$546.81A
$25.66B
$5,317.39C
View Top Conglomerate Stocks

Be the first to know about important HHS news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HHS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HHS ($2.53) is undervalued by 23.53% relative to our estimate of its Fair Value price of $3.30 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HHS ($2.53) is significantly undervalued by 23.53% relative to our estimate of its Fair Value price of $3.30 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HHS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HHS due diligence checks available for Premium users.

Valuation

HHS fair value

Fair Value of HHS stock based on Discounted Cash Flow (DCF)

Price
$2.53
Fair Value
$3.30
Undervalued by
23.41%
HHS ($2.53) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HHS ($2.53) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HHS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HHS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-18.04x
Industry
39.38x
Market
14.15x

HHS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.93x
Industry
7.48x
HHS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HHS's financial health

Profit margin

Revenue
$37.3M
Net Income
-$628.0k
Profit Margin
-1.7%
HHS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HHS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$90.4M
Liabilities
$70.3M
Debt to equity
3.5
HHS's short-term assets ($45.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HHS's short-term assets ($45.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HHS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HHS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$575.0k
Investing
-$347.0k
Financing
-$50.0k
HHS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HHS vs Conglomerate Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HHS$18.74M+2.68%-18.04x0.93x
LGPS$15.31M-12.20%N/A0.60x
NNBRC$158.32M+0.67%-2.75x6.07x
TUSKC$158.48M+3.13%14.95x0.60x
RCMTB$181.87M+2.35%11.88x4.11x

Harte Hanks Stock FAQ

What is Harte Hanks's quote symbol?

(NASDAQ: HHS) Harte Hanks trades on the NASDAQ under the ticker symbol HHS. Harte Hanks stock quotes can also be displayed as NASDAQ: HHS.

If you're new to stock investing, here's how to buy Harte Hanks stock.

What is the 52 week high and low for Harte Hanks (NASDAQ: HHS)?

(NASDAQ: HHS) Harte Hanks's 52-week high was $5.39, and its 52-week low was $2.22. It is currently -53.14% from its 52-week high and 13.78% from its 52-week low.

How much is Harte Hanks stock worth today?

(NASDAQ: HHS) Harte Hanks currently has 7,419,470 outstanding shares. With Harte Hanks stock trading at $2.53 per share, the total value of Harte Hanks stock (market capitalization) is $18.74M.

Harte Hanks stock was originally listed at a price of $123.33 in Dec 31, 1997. If you had invested in Harte Hanks stock at $123.33, your return over the last 28 years would have been -97.95%, for an annualized return of -12.97% (not including any dividends or dividend reinvestments).

How much is Harte Hanks's stock price per share?

(NASDAQ: HHS) Harte Hanks stock price per share is $2.53 today (as of Jun 12, 2026).

What is Harte Hanks's Market Cap?

(NASDAQ: HHS) Harte Hanks's market cap is $18.74M, as of Jun 14, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Harte Hanks's market cap is calculated by multiplying HHS's current stock price of $2.53 by HHS's total outstanding shares of 7,419,470.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.